I agree that this site is using cookies. You can find further informations here.
X
Klippel, Zandra
32  results:
Search for persons X
?
1

P931: ISATUXIMAB IN RELAPSED MULTIPLE MYELOMA PATIENTS WITH..:

Moreau, Philippe ; Perrot, Aurore ; Dimopoulos, Meletios A....
HemaSphere.  7 (2023)  S3 - p. e27700c7 , 2023
Link: https://doi.org/10.1097/..
 
?
2

MM-182 Allocation and Validation of the Second Revision of ..:

Perrot, Aurore ; Richardson, Paul ; Mikhael, Joseph...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S479-S480 , 2023
Link: https://doi.org/10.1016/..
 
?
3

POSTER: MM-246 Isatuximab (Isa) in Relapsed Multiple Myelom..:

Moreau, Philippe ; Perrot, Aurore ; Dimopoulos, Meletios-Athanasios...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S217 , 2023
Link: https://doi.org/10.1016/..
 
?
4

MM-246 Isatuximab (Isa) in Relapsed Multiple Myeloma (MM) P..:

Moreau, Philippe ; Perrot, Aurore ; Dimopoulos, Meletios-Athanasios...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S484 , 2023
Link: https://doi.org/10.1016/..
 
?
5

POSTER: MM-182 Allocation and Validation of the Second Revi..:

Perrot, Aurore ; Richardson, Paul ; Mikhael, Joseph...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S216 , 2023
Link: https://doi.org/10.1016/..
 
?
6

P968: ALLOCATION AND VALIDATION OF THE SECOND REVISION OF T..:

Perrot, Aurore ; Richardson, Paul ; Mikhael, Joseph...
HemaSphere.  7 (2023)  S3 - p. e3398301 , 2023
Link: https://doi.org/10.1097/..
 
?
7

Efficacy and safety of carfilzomib-based regimens in frail ..:

Facon, Thierry ; Niesvizky, Ruben ; Mateos, Maria-Victoria...
Blood Advances.  4 (2020)  21 - p. 5449-5459 , 2020
Link: https://doi.org/10.1182/..
 
?
8

Carfilzomib, dexamethasone, and daratumumab versus carfilzo..:

Dimopoulos, Meletios ; Quach, Hang ; Mateos, Maria-Victoria...
The Lancet.  396 (2020)  10245 - p. 186-197 , 2020
Link: https://doi.org/10.1016/..
 
?
9

Once‐weekly (70 mg/m2) vs twice‐weekly (56 mg/m2) dosing of..:

Moreau, Philippe ; Stewart, Keith A. ; Dimopoulos, Meletios...
Cancer Medicine.  9 (2020)  9 - p. 2989-2996 , 2020
Link: https://doi.org/10.1002/..
 
?
10

Carfilzomib (K) in relapsed and refractory multiple myeloma..:

Facon, Thierry ; Niesvizky, Ruben ; Weisel, Katja...
Clinical Lymphoma Myeloma and Leukemia.  19 (2019)  10 - p. e266 , 2019
Link: https://doi.org/10.1016/..
 
?
11

In response to: Treatment of patients with multiple myeloma..:

Klippel, Zandra ; Kimball, Amy ; Tekle, Christina
Blood Cancer Journal.  9 (2019)  12 - p. , 2019
Link: https://doi.org/10.1038/..
 
?
12

Carfilzomib (K) in Relapsed and Refractory Multiple Myeloma..:

Facon, Thierry ; Niesvizky, Ruben ; Weisel, Katja...
Clinical Lymphoma Myeloma and Leukemia.  19 (2019)  - p. S320 , 2019
Link: https://doi.org/10.1016/..
 
?
13

Oprozomib, pomalidomide, and Dexamethasone in Patients With..:

Shah, Jatin ; Usmani, Saad ; Stadtmauer, Edward A....
Clinical Lymphoma Myeloma and Leukemia.  19 (2019)  9 - p. 570-578.e1 , 2019
Link: https://doi.org/10.1016/..
 
?
14

A Randomized, Single-Blind Study Evaluating the Effect of a..:

Guinigundo, Andrew S. ; Maxwell, Cathy L. ; Vanni, Linda...
Pain Management Nursing.  19 (2018)  6 - p. 693-706 , 2018
Link: https://doi.org/10.1016/..
 
?
15

Value of incorporating newly identified risk factors into r..:

Li, Yanli ; Family, Leila ; Chen, Lie H....
Cancer Medicine.  7 (2018)  8 - p. 4121-4131 , 2018
Link: https://doi.org/10.1002/..
 
1-15